Lakeland Industries, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – LAKE
LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Lakeland Industries, Inc. (“Lakeland” or “the... Read more.
PHINIA to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2026 Investor Day
AUBURN HILLS, Mich.–(BUSINESS WIRE)–PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions, is hosting... Read more.
Acacia Research to Release Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
NEW YORK–(BUSINESS WIRE)–Acacia Research Corporation (NASDAQ: ACTG) (“Acacia” or the “Company”), which acquires and operates businesses across... Read more.
ProCap Financial Stays in Attack Mode as NAV Discount Begins to Close
ProCap Financial repurchased 158,796 shares on Tuesday, February 24, 2026 at approximately 30% discount to NAV Company is committed to aggressively repurchasing... Read more.
IGI Declares Extraordinary Cash Dividend
HAMILTON, Bermuda–(BUSINESS WIRE)–International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that... Read more.
Corcept Therapeutics Incorporated Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – CORT
LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated (“Corcept” or... Read more.
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
We estimate that MRD represents a $20+ billion addressable market, growing at 30% annually, which we believe is less than 10% penetrated FORT MYERS, Fla.–(BUSINESS... Read more.
Metropolitan Bank Holding Corp. to Host Investor Day on March 3
NEW YORK–(BUSINESS WIRE)–#mcb–Metropolitan Bank Holding Corp. (the “Company”) (NYSE: MCB), the holding company for Metropolitan Commercial... Read more.
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
– LINZESS® (linaclotide) EUTRx demand growth of 11% for full year 2025 year-over-year – – 2025 Ironwood revenue of $296 million, GAAP net income of $24 million... Read more.
Lumen Marks New Phase of Transformation at 2026 Investor Day
Declares completion of turnaround and outlines multi-year growth plan Updates key initiatives supporting company’s position as the trusted network for AI, including... Read more.